Owens & Minor (OMI)
(Delayed Data from NYSE)
$18.62 USD
-0.49 (-2.56%)
Updated May 17, 2024 04:00 PM ET
After-Market: $18.62 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$18.62 USD
-0.49 (-2.56%)
Updated May 17, 2024 04:00 PM ET
After-Market: $18.62 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Zacks News
Top Ranked Growth Stocks to Buy for August 5th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, August 5th.
Owens & Minor (OMI) Tops Q2 Earnings Estimates
by Zacks Equity Research
Owens & Minor (OMI) delivered earnings and revenue surprises of 5.26% and -4.77%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
4 Price-to-Book Value Picks to Buy in August
by Kinjel Shah
P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects.
Top Ranked Growth Stocks to Buy for August 4th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, August 4th
Owens & Minor (OMI) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Surging Earnings Estimates Signal Upside for Owens & Minor (OMI) Stock
by Zacks Equity Research
Owens & Minor (OMI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Owens & Minor, Inc. (OMI) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Owens & Minor, Inc. (OMI).
Top Ranked Growth Stocks to Buy for July 24th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 24th
Is Owens & Minor (OMI) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Owens & Minor (OMI) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Amedisys (AMED) Broadens Hospice Base With AseraCare Buyout
by Zacks Equity Research
Amedisys (AMED) expects AseraCare business to add greater scale to its existing nationwide network.
Medtronic Alters ECMO Therapy on New FDA Rules for Coronavirus
by Zacks Equity Research
Medtronic (MDT), in response to the FDA's new guidance due to the coronavirus-led health emergency, has made temporary alterations to its cardiopulmonary product indications for use in ECMO therapy.
Tandem Diabetes Rides on Control-IQ Amid Coronavirus Crisis
by Zacks Equity Research
Strong domestic pump sales and international expansion boosts sales of Tandem Diabetes (TNDM).
Here's Why You Should Hold on to Tandem Diabetes Stock for Now
by Zacks Equity Research
Investors continue to be optimistic about Tandem Diabetes (TNDM) on robust pump sales and international growth.
QIAGEN Sales Grow on Coronavirus Solutions Ahead of Selloff
by Zacks Equity Research
QIAGEN (QGEN) ramps up production capacity of solutions currently being used for testing purposes.
Thermo Fisher (TMO) Partners With CSL to Expand Pharma Arm
by Zacks Equity Research
Thermo Fisher (TMO), through its alliance with CSL, expands Pharma Services arm to meet the rising demand for biologic therapies.
Quest Diagnostics' Self-Collection Coronavirus Kit Gets EUA
by Zacks Equity Research
This kit by Quest Diagnostics (DGX) is suitable for use in children supervised by an adult.
LabCorp Partners With Medable to Expand Technology Ecosystem
by Zacks Equity Research
LabCorp (LH) expands technology ecosystem to accelerate the adoption of decentralized clinical trials by collaborating with Medable.
Zimmer Biomet Faces Procedure Delays, Long-Term Potential Solid
by Zacks Equity Research
Zimmer Biomet (ZBH) believes COVID-19 to continue to have a significant unfavorable impact on its sales in the near term.
Here's Why You Should Hold on to Chemed (CHE) Stock for Now
by Zacks Equity Research
Investors continue to be optimistic about Chemed (CHE) on robust segmental growth.
Teleflex (TFX) Rides on UroLift Sales Amid Coronavirus Mayhem
by Zacks Equity Research
NeoTract, the acquired business of Teleflex (TFX), continues to perform impressively.
IDEXX Sees Higher Clinical Visits Despite Coronavirus Crisis
by Zacks Equity Research
IDEXX (IDXX) notes a significant improvement in U.S. clinical visit trends across major regions.
Henry Schein Sales Drop on Coronavirus Woes, Costs Rise
by Zacks Equity Research
Henry Schein (HSIC) registers dismal performance within Dental business on suspension of non-emergency procedures in response to the pandemic.
Medtronic Gets FDA Nod for Guardian CGM's Android Version
by Zacks Equity Research
Medtronic (MDT) expands reach to diabetic patients by introducing the Guardian Connect CGM system's Android version post its FDA clearance.
Should Value Investors Buy Owens & Minor (OMI) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.